Research Summary
Immuno-oncology is a branch of cancer treatment that focuses on harnessing the body's immune system to recognize, target, and eliminate cancer cells. The field explores strategies to enhance the natural ability of the immune system to detect and destroy cancer cells, often by overcoming mechanisms that tumors use to evade immune detection. Immunotherapies in immuno-oncology include checkpoint inhibitors, adoptive cell transfer, cytokines, and cancer vaccines. Checkpoint inhibitors, such as PD-1 and CTLA-4 inhibitors, block proteins that inhibit immune responses, allowing T cells to recognize and attack cancer cells more effectively. Adoptive cell transfer involves manipulating a patient's own immune cells outside the body and then reintroducing them to target and destroy cancer cells. Immuno-oncology has shown promising results in treating various types of cancers and is a rapidly evolving field in the quest for more effective and targeted cancer therapies.
According to DIResearch's in-depth investigation and research, the global Immuno-Oncology market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Immuno-Oncology include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Immuno-Oncology. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Immuno-Oncology market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Immuno-Oncology market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Immuno-Oncology industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Immuno-Oncology Include:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Immuno-Oncology Product Segment Include:
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Immuno-Oncology Product Application Include:
Hospitals
Drugstores
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Immuno-Oncology Industry PESTEL Analysis
Chapter 3: Global Immuno-Oncology Industry Porter's Five Forces Analysis
Chapter 4: Global Immuno-Oncology Major Regional Market Size and Forecast Analysis
Chapter 5: Global Immuno-Oncology Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Immuno-Oncology Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Immuno-Oncology Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Immuno-Oncology Market Overview 1.1 Product Definition and Statistical Scope 1.2 Immuno-Oncology Product by Type 1.2.1 Global Immuno-Oncology Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Immune Checkpoint Inhibitors 1.2.3 Cytokine-Based Immunotherapy 1.2.4 Cancer Vaccines 1.2.5 CAR-T Cell Therapy 1.2.6 Others 1.3 Immuno-Oncology Product by Application 1.3.1 Global Immuno-Oncology Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Hospitals 1.3.3 Drugstores 1.3.4 Others 1.4 Global Immuno-Oncology Market Revenue Analysis (2019-2030) 1.5 Immuno-Oncology Market Development Status and Trends 1.5.1 Immuno-Oncology Industry Development Status Analysis 1.5.2 Immuno-Oncology Industry Development Trends Analysis 2 Immuno-Oncology Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Immuno-Oncology Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Immuno-Oncology Market Analysis by Regions 4.1 Immuno-Oncology Overall Market: 2023 VS 2024 VS 2030 4.2 Global Immuno-Oncology Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Immuno-Oncology Revenue and Market Share by Region (2019-2024) 4.2.2 Global Immuno-Oncology Revenue Forecast by Region (2025-2030) 5 Global Immuno-Oncology Market Size by Type and Application 5.1 Global Immuno-Oncology Market Size by Type 5.2 Global Immuno-Oncology Market Size by Application 6 North America 6.1 North America Immuno-Oncology Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Immuno-Oncology Market Size by Type 6.4 North America Immuno-Oncology Market Size by Application 6.5 North America Immuno-Oncology Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Immuno-Oncology Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Immuno-Oncology Market Size by Type 7.4 Europe Immuno-Oncology Market Size by Application 7.5 Europe Immuno-Oncology Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Immuno-Oncology Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Immuno-Oncology Market Size by Type 8.4 China Immuno-Oncology Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Immuno-Oncology Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Immuno-Oncology Market Size by Type 9.4 APAC (excl. China) Immuno-Oncology Market Size by Application 9.5 APAC (excl. China) Immuno-Oncology Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Immuno-Oncology Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Immuno-Oncology Market Size by Type 10.4 Latin America Immuno-Oncology Market Size by Application 10.5 Latin America Immuno-Oncology Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Immuno-Oncology Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Immuno-Oncology Market Size by Type 11.4 Middle East & Africa Immuno-Oncology Market Size by Application 11.5 Middle East & Africa Immuno-Oncology Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Immuno-Oncology Market Revenue by Key Manufacturers (2020-2024) 12.2 Immuno-Oncology Competitive Landscape Analysis and Market Dynamic 12.2.1 Immuno-Oncology Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Bristol-Myers Squibb 13.1.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Bristol-Myers Squibb Immuno-Oncology Product Portfolio 13.1.3 Bristol-Myers Squibb Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Merck & Co., Inc. 13.2.1 Merck & Co., Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Merck & Co., Inc. Immuno-Oncology Product Portfolio 13.2.3 Merck & Co., Inc. Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Roche AG 13.3.1 Roche AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Roche AG Immuno-Oncology Product Portfolio 13.3.3 Roche AG Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 AstraZeneca, Plc 13.4.1 AstraZeneca, Plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 AstraZeneca, Plc Immuno-Oncology Product Portfolio 13.4.3 AstraZeneca, Plc Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Sanofi S.A. 13.5.1 Sanofi S.A. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Sanofi S.A. Immuno-Oncology Product Portfolio 13.5.3 Sanofi S.A. Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Dendreon Pharmaceuticals 13.6.1 Dendreon Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Portfolio 13.6.3 Dendreon Pharmaceuticals Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Novartis 13.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Novartis Immuno-Oncology Product Portfolio 13.7.3 Novartis Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Gilead Sciences Inc. 13.8.1 Gilead Sciences Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Gilead Sciences Inc. Immuno-Oncology Product Portfolio 13.8.3 Gilead Sciences Inc. Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Merck KGaA 13.9.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Merck KGaA Immuno-Oncology Product Portfolio 13.9.3 Merck KGaA Immuno-Oncology Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Immuno-Oncology Industry Chain Analysis 14.2 Immuno-Oncology Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Immuno-Oncology Typical Downstream Customers 14.4 Immuno-Oncology Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support